GlassScriptPhysician profile
Jennifer Lynn Meadows
NPI 1225247349
$2,244.30
in general payments reported to CMS, 2019-2025
35 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $196 · 2021: $490 · 2022: $262 · 2023: $246 · 2024: $247 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.74 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $367.57 | 2019-2025 | Aptima, Acessa Provu System, Novasure |
| Abbvie INC. | $316.34 | 2019-2022 | |
| Lupin INC. | $126.11 | 2019-2020 | |
| Astellas Pharma US INC | $120.70 | 2023-2025 | Veozah |
| Evofem Biosciences, INC. | $107.23 | 2020-2024 | |
| Therapeuticsmd, INC. | $87.15 | 2019-2022 | |
| Exeltis, USA INC. | $86.26 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $85.39 | 2019-2021 | |
| Biogen, INC. | $84.15 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $74.50 | 2022-2025 | |
| Agile Therapeutics, INC. | $73.87 | 2021-2022 | |
| Shield Therapeutics INC | $66.57 | 2024 | |
| Coopersurgical, INC. | $57.85 | 2019-2025 | Paragard T 380a |
| Medtronic, INC. | $51.64 | 2023 | Ligasure |
| Smith+Nephew, INC. | $40.31 | 2022-2025 | Pico |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $40.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Covidien LP | $39.39 | 2019-2020 | |
| Scynexis, INC. | $37.70 | 2022 | |
| Organon LLC | $36.97 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.69 | 2019-2021 | |
| Roche Diagnostics Corporation | $34.16 | 2019-2020 | |
| Minerva Surgical, INC | $29.51 | 2019-2023 | |
| Ethicon US, LLC | $29.29 | 2019-2023 | Ethicon |
| Millicent US INC | $28.11 | 2023-2024 | Intrarosa |
| Alexion Pharmaceuticals, INC. | $26.60 | 2022 | |
| Sage Therapeutics, LLC | $21.27 | 2021 | |
| Amag Pharmaceuticals, INC. | $17.71 | 2019 | |
| Dysis Medical, INC. | $16.53 | 2021 | |
| Sumitomo Pharma America, INC. | $15.85 | 2023 | Myfembree |
| Channel Medsystems, INC. | $15.79 | 2024 | |
| Acessa Health INC. | $15.76 | 2020 | |
| Duchesnay USA Incorporated | $15.64 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.23 | 2019 | |
| Davol INC. | $15.07 | 2021 | |
| Allergan, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Meadows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.